---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-014389"
form_type: "8-K"
ticker: "LSH"
cik: "0001996192"
company_name: "Lakeside Holding Ltd"
filed_at: "2025-02-14T23:59:59+00:00"
generated_at: "2026-05-26T21:43:27.984637+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Lakeside Q2 revenue fell 27% to $3.6M; net loss $1.9M vs prior-year profit

## Summary
- Q2 revenue $3.6M down 26.9% YoY; net loss $1.9M vs net income $0.06M.
- H1 revenue $7.7M down 15.3%; gross profit collapsed to $0.5M from $1.7M; margin 5.1% vs 18.9%.
- Airfreight volume halved to 4,459 tons; Asia-based customer revenue up 29.4% in H1.
- Acquired Hupan Pharmaceutical for $0.6M; pharma segment added $0.2M in Q2.
- Signed $1.5M one-year drug supply deal with Sinopharm subsidiary; Dallas warehouse doubled.

## SEC filing metadata
- accession: 0001213900-25-014389
- form_type: 8-K
- ticker: LSH
- cik: 0001996192
- company_name: Lakeside Holding Ltd
- filed_at: 2025-02-14T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1996192/000121390025014389/0001213900-25-014389-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1996192/000121390025014389/ea0231248-8k_lakeside.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-014389
- JSON: https://secwatch.observer/filing/0001213900-25-014389.json
- Plain text: https://secwatch.observer/filing/0001213900-25-014389.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.